Press Release

Keensight Capital to acquire majority stake in Quanos

By WeAreBlowDecember 20, 2022No Comments

Download Télécharger

Previous PostSymeres acquires Oncolines, further strengthening its drug discovery and biology capabilities
Next PostValiantys and Expium join forces to strengthen its leading position as a global Atlassian partner, with the support of Keensight Capital